PageGoblin PageGoblin

The Hoard / E-commerce

flexoplexstore.com landing page review.

Goblin scored flexoplexstore.com 6.5/10 across twelve conversion dimensions on 29 Sep, 2026.

Goblin's Score

6.5

Out Of 10

"Goblin sees a page that knows its job—sell joint relief—but buries real pricing under layers of popup noise and survey asterisks."

flexoplexstore.com

/

29 Sep, 2026

Full Report

7/10

Hero clarity

Headline hits the problem ('Tried Everything for Joint Pain?'), but subheadline is soft on specifics—'trusted by thousands' is vague without a number or outcome.

What You Got Right

  • Problem-led headline resonates with the target audience immediately.

    • What's Wrong

  • Subheadline 'trusted by thousands' lacks specificity—no user count, no years in market, no concrete outcome named.
  • 'Whether you're 35 or 65' is too broad; stronger positioning would pick a primary age or life stage.

    • 8/10

    CTA prominence

    CTA is present and visible above fold ('try flexoplex risk-free'), but it competes with three pop-up offers and a timer, creating visual chaos.

    What You Got Right

  • Primary CTA text is concrete and trust-focused: 'try flexoplex risk-free' beats generic 'Learn more'.

    • What's Wrong

  • Multiple CTAs above fold (the risk-free button, countdown timer, fall sale banner) dilute focus and pressure visitors.
  • Pop-up upsells (6-bottle, 4-bottle, 2-bottle offers) appear immediately, risking abandonment before hero message lands.

    • 6/10

    Value prop specificity

    Page claims '95% saw improved flexibility' and '94% reported less inflammation' but buries the asterisk disclaimer that this is a survey, not a clinical study.

    What You Got Right

  • Numbers are present and concrete (95%, 94%, 4 weeks, 2 weeks).

    • What's Wrong

  • Disclaimer in small text immediately undercuts credibility: 'subjective survey, results may vary.' This should be integrated into messaging or omitted entirely.
  • Core benefit is scattered across four separate text blocks instead of one cohesive value statement.

    • 5/10

    Trust signals

    Page claims '250,000+ users' but hides this in the footer. Above fold shows only rotating testimonial carousel images and a '60-day guarantee' badge—no named faces, no verified reviews, no logos.

    What You Got Right

  • 60-day money-back guarantee is visible and clear.

    • What's Wrong

  • User count (250,000+) buried in footer copy, not above fold; should anchor hero.
  • Testimonial carousel above fold shows no names, no faces, no detail—just generic statements like 'Fast joint relief' with empty image placeholders.

    • 7/10

    Copy concreteness

    Ingredient section shines with specific dosing benefits ('Repairs cartilage', 'Lubricates joints'), but broader copy leans on marketing softness: 'Real support. Fast relief. Nothing extra—just what works.'

    What You Got Right

  • Ingredient carousel names each compound with 2–3 specific actions per ingredient (e.g., 'Glucosamine: Repairs cartilage, Supports joint mobility').

    • What's Wrong

  • Claims like 'Flexoplex is different' and 'Real support' lack evidence or specifics; needs numbers or named comparisons.
  • 'Starts working within days' is vague—contradicts later messaging that results take 2–4 weeks.

    • 6/10

    Social proof depth

    Named customers appear (Raymond Jewell, Andrea Fritz, Denise Davis) with testimonials, but page undercuts them with fine-print disclaimer that users were given free product.

    What You Got Right

  • Six named customers with video testimonials and context (e.g., 'Andrea can enjoy hiking again without hip or knee pain').

    • What's Wrong

  • Disclaimer states users were 'provided with a free product in exchange for their honest feedback'—weakens credibility.
  • Survey stats ('99% reported reduction in joint pain') lack verification detail—no third-party source, no methodology, no sample size.

    • 7/10

    Objection handling

    FAQ and guarantee sections address main fears (cost, results timeline, side effects), but 'Is it safe?' is answered vaguely: 'made in an FDA-registered facility'—not FDA-approved.

    What You Got Right

  • FAQ directly tackles six objections: results timeline, daily safety, allergens, prescription need, refund, subscription lock-in.

    • What's Wrong

  • Safety claim conflates 'FDA-registered facility' (common) with safety approval—could confuse buyers.
  • Lock-in fear is addressed, but no mention of competitor comparisons or why Flexoplex is different besides ingredient count.

    • 6/10

    Visual hierarchy

    Page structure is logical (hero → benefits → ingredients → testimonials → pricing), but four pop-up modals and a sticky countdown timer fragment attention.

    What You Got Right

  • Content sections flow logically: problem → solution → proof → action.

    • What's Wrong

  • Pop-up interruptions (6-bottle, 4-bottle, 2-bottle upsells) break reading flow and risk immediate exit.
  • Countdown timer and rotating 'Fall Sale' banners create urgency fatigue—visitor can't focus on core message.

    • 6/10

    Mobile rendering

    HTML lacks viewport meta tag in head (preprocessed, but typical Elementor sites have it). Carousel and accordion are responsive, but pop-ups likely scale poorly on small screens.

    What You Got Right

  • Ingredient carousel and testimonial carousels include responsive image sizes (srcset, sizes attributes).

    • What's Wrong

  • Multiple nested containers and nested carousels may cause layout thrashing on mobile.
  • Pop-up offer modals with large images could exceed viewport height on phones; CTA buttons may be small.

    • 5/10

    Page speed signals

    Page loads multiple high-resolution product images (800x800px carousels), several pop-up modals with images, and a countdown timer script—likely slow on 3G.

    What You Got Right

  • Images use lazy loading ('loading=lazy', 'decoding=async') and responsive srcset attributes.

    • What's Wrong

  • Eleven product images in nested carousels, each 532x532px or larger; no WebP fallback visible.
  • Pop-up modals and countdown timer widgets add DOM bloat and likely render-blocking script tags (stripped in preprocessing).

    • 8/10

    Form and CTA friction

    Primary CTA ('try flexoplex risk-free') links directly to order section with no intermediate form gate; friction is low. Pricing tiers are visible before checkout.

    What You Got Right

  • No email gate or form wall before pricing is revealed; buyers can see cost and options immediately.

    • What's Wrong

  • Pop-up offers force an upsell decision before allowing progression to standard order page.

    • 7/10

    Pricing clarity

    Pricing is visible and quantified ('$44.99' for one bottle, '$34.99/bottle' for five-bottle pack), but the page buries subscribe-and-save savings behind multiple tabs and pop-up offers.

    What You Got Right

  • Three clear tiers: 1 bottle ($44.99), 3 bottles ($39.99 ea.), 5 bottles ($34.99 ea.) with savings shown per bottle.

    • What's Wrong

  • Subscribe-and-save discount (25% off) is mentioned in heading but not quantified per tier in the main pricing table.
  • Pop-up upsells ('Buy 6 bottles + 1 Flexdermal Free for $32.99 ea.') introduce pricing confusion—unclear if this is a limited-time offer or standard option.

    • Priority Fixes

  • Remove or defer all pop-up upsells below fold; let hero and core benefits land first before introducing 'Buy 6 + 1 Free' noise.
  • Anchor the '250,000+ users' stat and verified review count above fold to replace vague 'trusted by thousands' language.
  • Clarify pricing: consolidate subscribe-and-save discount percentages into the main pricing table, and flag limited-time offers separately from standard tiers.

    • Things Goblin Respected

  • Ingredient carousel names each compound with specific actions (e.g., 'Repairs cartilage', 'Fights inflammation')—concrete over vague.
  • 60-day money-back guarantee is prominent and removes purchase risk; copy is honest about return process.
  • Named customers with testimonials and real outcomes (e.g., 'Andrea can enjoy hiking again') beat generic 'People love this' fluff.